Besides antigen-dependent BCR stimulation, SYK activity has also been shown to be regulated by mutated MYD88L256P that forms the myddosome signaling complex and activates STAT3 and Akt signaling in MYD88L256P lymphoma cells [168]. The gene discussed is SYK; the disease is lymphoma.